# XPER (Xperi Inc.) - SEC EDGAR Financial Statements

> Xperi Inc. reported $459.2M in revenue and a net loss of $31.65M for the trailing twelve months ended September 30, 2026 (up 2.1% year over year), with a 70.0% gross margin and a -1.7% operating margin.

- Canonical: https://convexityos.com/fundamentals/XPER
- Markdown: https://convexityos.com/fundamentals/XPER.md
- SEC CIK: 0001788999
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:41 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001788999&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $459.2M | +2.1% YoY |
| Operating Income | TTM | -$7.97M | -1.7% margin |
| Net Income | TTM | -$31.65M | -6.9% net margin |
| Diluted EPS | TTM | -$0.65 | Split-adjusted |
| Free Cash Flow | TTM | -$633K | -0.1% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $87.03M | Total debt: $63.52M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $448.1M | $493.7M | $521.3M | $502.3M | $486.5M | $376.1M |
| Cost of Revenue | $126.6M | $113.8M | $118.6M | $122.9M | $125.6M | $77.79M |
| **Gross Profit** | $321.5M | $379.9M | $402.7M | $379.3M | $360.9M | $298.3M |
| Research & Development | $135.1M | $191.4M | $222.8M | $216.4M | $194.9M | $163.4M |
| Selling, General & Admin | $181.9M | $218.1M | $233.4M | $217.4M | $199.9M | $172.6M |
| **Operating Income** | -$43.73M | -$87.08M | -$129.6M | -$749.4M | -$161.8M | -$152.6M |
| **EBITDA** | $4.53M | -$31.06M | -$55.24M | -$666.7M | -$33.93M | -$37.69M |
| Interest Expense | $2.98M | $3.01M | $3.00M | $1.51M | -- | -- |
| Income Before Tax | -$40.62M | $11.58M | -$129.6M | -$747.6M | -$160.2M | -$151.0M |
| Income Tax Expense | $15.72M | $12.45M | $10.04M | $13.59M | $18.84M | -$9.73M |
| **Net Income** | -$56.34M | -$14.01M | -$136.6M | -$757.5M | -$175.6M | -$138.3M |
| Basic EPS | -$1.23 | -$0.31 | -$3.18 | -$18.02 | -$4.18 | -$3.29 |
| **Diluted EPS** | -$1.23 | -$0.31 | -$3.18 | -$18.02 | -$4.18 | -$3.29 |
| Basic Shares Outstanding | 45.9M | 45.1M | 43.0M | 42.0M | 42.0M | 42.0M |
| Diluted Shares Outstanding | 45.9M | 45.1M | 43.0M | 42.0M | 42.0M | 42.0M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $114.0M | $114.5M | $114.2M | $116.5M | $111.6M | $105.9M | $114.0M | $122.4M |
| Cost of Revenue | -- | -- | $30.88M | $34.42M | $29.08M | $33.55M | $29.60M | $27.56M |
| **Gross Profit** | -- | -- | $83.33M | $82.08M | $82.55M | $72.38M | $84.43M | $94.80M |
| Research & Development | $23.49M | $21.81M | $27.08M | $35.80M | $29.92M | $29.78M | $39.55M | $42.16M |
| Selling, General & Admin | $41.65M | $41.46M | $41.79M | $49.49M | $42.54M | $41.14M | $48.70M | $52.17M |
| **Operating Income** | $1.76M | $2.91M | $2.15M | -$14.80M | -$1.36M | -$11.13M | -$16.44M | -$14.29M |
| **EBITDA** | $13.32M | $14.96M | $14.46M | -$3.21M | $10.10M | $1.46M | -$3.81M | -$1.07M |
| Interest Expense | $694K | $684K | $678K | $727K | $761K | $759K | $732K | $756K |
| Income Before Tax | $2.14M | $3.33M | $2.29M | -$14.29M | -$1.30M | -$10.14M | -$14.88M | $58.98M |
| Income Tax Expense | $7.38M | $4.83M | $10.12M | $2.79M | $4.80M | $4.64M | $3.49M | -$3.99M |
| **Net Income** | -$5.24M | -$1.50M | -$7.83M | -$17.09M | -$6.11M | -$14.78M | -$18.37M | $46.22M |
| Basic EPS | -$0.11 | -$0.03 | -$0.17 | -- | -$0.13 | -$0.32 | -$0.41 | -- |
| **Diluted EPS** | -$0.11 | -$0.03 | -$0.17 | -- | -$0.13 | -$0.32 | -$0.41 | -- |
| Basic Shares Outstanding | 48.8M | 48.4M | 47.4M | -- | 46.3M | 45.8M | 44.8M | -- |
| Diluted Shares Outstanding | 48.8M | 48.4M | 47.4M | -- | 46.3M | 45.8M | 44.8M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $96.82M | $130.6M | $142.1M | $160.1M | $120.7M |
| **Cash & Short-Term Investments** | $96.82M | $130.6M | $142.1M | $160.1M | $120.7M |
| Accounts Receivable, Net | $56.84M | $58.74M | $55.98M | $64.71M | $79.49M |
| Inventory | -- | -- | -- | $6.66M | $5.10M |
| Other Current Assets | $23.63M | $32.49M | $38.87M | $42.17M | $25.98M |
| **Total Current Assets** | $267.5M | $304.9M | $316.9M | $332.3M | $277.1M |
| Property, Plant & Equipment, Net | $51.93M | $44.47M | $41.57M | $47.83M | $57.48M |
| Goodwill | $0 | -- | -- | $0 | $536.5M |
| Intangible Assets | $128.9M | $163.7M | $206.9M | $264.4M | $270.9M |
| Other Non-Current Assets | $27.33M | $24.08M | $32.78M | $33.16M | $19.22M |
| **Total Non-Current Assets** | $348.3M | $362.9M | $356.7M | $404.6M | $951.6M |
| **Total Assets** | $615.8M | $667.8M | $673.6M | $736.9M | $1.23B |
| Accounts Payable | $12.35M | $16.98M | $20.85M | $14.86M | $7.36M |
| Short-Term Debt | $0 | $50.00M | -- | -- | -- |
| Deferred Revenue (Current) | $16.14M | $23.95M | $28.11M | $25.36M | $28.21M |
| **Total Current Liabilities** | $110.6M | $185.3M | $165.1M | $150.2M | $120.0M |
| Long-Term Debt | $40.00M | $0 | $50.00M | $50.00M | -- |
| Deferred Revenue (Non-Current) | $15.07M | $20.93M | $19.43M | $19.13M | $23.66M |
| Other Non-Current Liabilities | $13.12M | $10.98M | $4.58M | $12.99M | $5.67M |
| **Total Non-Current Liabilities** | $91.11M | $53.33M | $121.4M | $137.7M | $92.78M |
| **Total Liabilities** | $201.8M | $238.7M | $286.5M | $287.9M | $212.8M |
| **Total Debt (incl. Leases)** | $70.34M | $85.28M | $95.36M | $109.9M | $63.74M |
| Common Stock | $47K | $44K | $44K | $42K | -- |
| Retained Earnings | -$895.8M | -$839.4M | -$805.4M | -$668.8M | -- |
| Accumulated Other Comp. Income | -$4.44M | -$6.08M | -$2.87M | -$4.12M | -$676K |
| **Total Stockholders' Equity** | -- | $429.1M | $404.2M | $463.4M | $1.03B |
| Total Equity | $414.1M | $429.1M | $387.1M | $449.0M | $1.02B |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $87.03M | $90.59M | $70.42M | $96.82M | $96.78M | $95.15M | $87.99M | $130.6M |
| **Cash & Short-Term Investments** | $87.03M | $90.59M | $70.42M | $96.82M | $96.78M | $95.15M | $87.99M | $130.6M |
| Accounts Receivable, Net | $62.19M | $61.91M | $59.90M | $56.84M | $56.82M | $59.79M | $58.19M | $58.74M |
| Other Current Assets | $26.91M | $26.86M | $28.68M | $23.63M | $29.55M | $35.76M | $36.60M | $32.49M |
| **Total Current Assets** | $291.8M | $283.6M | $260.9M | $267.5M | $273.1M | $283.7M | $266.7M | $304.9M |
| Property, Plant & Equipment, Net | $59.73M | $54.99M | $51.47M | $51.93M | $50.47M | $46.93M | $45.70M | $44.47M |
| Goodwill | $3.33M | $3.33M | -- | $0 | -- | -- | -- | -- |
| Intangible Assets | $105.3M | $113.2M | $120.8M | $128.9M | $136.9M | $144.9M | $154.0M | $163.7M |
| Other Non-Current Assets | $28.31M | $28.53M | $28.27M | $27.33M | $27.67M | $24.04M | $25.67M | $24.08M |
| **Total Non-Current Assets** | $333.0M | $332.4M | $346.0M | $348.3M | $355.7M | $345.6M | $366.8M | $362.9M |
| **Total Assets** | $624.8M | $615.9M | $606.9M | $615.8M | $628.8M | $629.2M | $633.5M | $667.8M |
| Accounts Payable | $13.65M | $16.95M | $12.60M | $12.35M | $17.09M | $14.95M | $14.54M | $16.98M |
| Short-Term Debt | -- | -- | -- | $0 | $0 | $0 | -- | $50.00M |
| Deferred Revenue (Current) | $12.64M | $14.93M | $15.40M | $16.14M | $17.76M | $20.32M | $24.03M | $23.95M |
| **Total Current Liabilities** | $122.5M | $114.2M | $110.4M | $110.6M | $113.0M | $113.4M | $117.7M | $185.3M |
| Long-Term Debt | $40.00M | $40.00M | $40.00M | $40.00M | $40.00M | $40.00M | $40.00M | $0 |
| Deferred Revenue (Non-Current) | $10.15M | $11.72M | $13.66M | $15.07M | $16.59M | $17.78M | $18.87M | $20.93M |
| Other Non-Current Liabilities | $18.08M | $15.88M | $13.89M | $13.12M | $13.16M | $12.44M | $12.11M | $10.98M |
| **Total Non-Current Liabilities** | $85.72M | $86.69M | $88.57M | $91.11M | $94.73M | $95.97M | $96.83M | $53.33M |
| **Total Liabilities** | $208.2M | $200.9M | $198.9M | $201.8M | $207.8M | $209.4M | $214.6M | $238.7M |
| **Total Debt (incl. Leases)** | $63.52M | $65.17M | $67.65M | $70.34M | $73.03M | $74.21M | $75.39M | $85.28M |
| Common Stock | $49K | $49K | $48K | $47K | $46K | $46K | $45K | $44K |
| Retained Earnings | -$910.4M | -$905.1M | -$903.6M | -$895.8M | -$878.7M | -$872.6M | -$857.8M | -$839.4M |
| Accumulated Other Comp. Income | -$6.54M | -$6.46M | -$6.27M | -$4.44M | -$3.63M | -$1.59M | -$3.89M | -$6.08M |
| **Total Stockholders' Equity** | -- | -- | -- | -- | -- | -- | -- | $429.1M |
| Total Equity | $416.6M | $415.1M | $408.0M | $414.1M | $421.0M | $419.8M | $418.9M | $429.1M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$56.34M | -$869K | -$139.7M | -$761.2M | -$179.1M | -$141.3M |
| Depreciation & Amortization | $48.27M | $56.01M | $74.40M | $82.71M | $127.9M | $114.9M |
| Stock-Based Compensation | $40.68M | $60.54M | $69.53M | $45.30M | $33.51M | $19.18M |
| Change in Receivables | -$586K | -$5.50M | $5.72M | $17.50M | -$2.42M | -$10.83M |
| Change in Payables | -$4.70M | -$3.04M | $5.07M | $6.63M | -$4.02M | -$3.11M |
| **Operating Cash Flow** | -$515K | -$55.34M | $62K | -$28.45M | -$23.45M | -$23.78M |
| Capital Expenditure | -$5.38M | -$5.04M | -$6.82M | -$13.10M | -$8.89M | -$6.60M |
| **Free Cash Flow** | -$5.90M | -$60.38M | -$6.75M | -$41.55M | -$32.35M | -$30.38M |
| **Investing Cash Flow** | -$20.98M | $50.82M | -$12.93M | -$64.85M | -$21.48M | $26.52M |
| Common Stock Issued | $5.97M | $7.86M | $11.93M | -- | -- | -- |
| Share Repurchases | $0 | -$19.99M | $0 | -- | -- | -- |
| **Financing Cash Flow** | -$12.24M | -$19.35M | $7.05M | $135.8M | $83.33M | $34.24M |
| **Net Change in Cash** | -$33.74M | -$23.87M | -$5.69M | $39.43M | $35.07M | $38.36M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$5.24M | -$1.50M | -$7.83M | -$17.09M | -$6.11M | -$14.78M | -$18.37M | $62.96M |
| Depreciation & Amortization | $11.55M | $12.04M | $12.30M | $11.59M | $11.46M | $12.59M | $12.63M | $13.22M |
| Stock-Based Compensation | $7.01M | $6.83M | $7.84M | $8.61M | $9.64M | $10.33M | $12.10M | $15.23M |
| Change in Receivables | -$446K | -$2.44M | -$2.91M | -$2.03M | $2.89M | -$1.68M | $233K | $3.06M |
| Change in Payables | -$4.26M | $3.69M | $1.02M | -$3.22M | $522K | $656K | -$2.65M | -$2.71M |
| **Operating Cash Flow** | $4.09M | $14.56M | -$18.02M | $4.10M | $7.54M | $10.11M | -$22.26M | $1.23M |
| Capital Expenditure | -$820K | -$497K | -$1.10M | -$2.94M | -$812K | -$561K | -$1.07M | -$1.74M |
| **Free Cash Flow** | $3.27M | $14.06M | -$19.12M | $1.16M | $6.72M | $9.55M | -$23.32M | -$510K |
| **Investing Cash Flow** | -$7.47M | -$6.95M | -$4.83M | -$6.38M | -$5.62M | -$4.78M | -$4.21M | $63.68M |
| **Financing Cash Flow** | -$187K | $12.55M | -$3.55M | $2.32M | -$279K | $1.83M | -$16.11M | -$7.03M |
| **Net Change in Cash** | -$3.56M | $20.17M | -$26.40M | $40K | $1.64M | $7.16M | -$42.58M | $57.88M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 71.7% | 77.0% | 77.2% | 75.5% | 74.2% | 79.3% |
| **Operating Margin** | -9.8% | -17.6% | -24.9% | -149.2% | -33.3% | -40.6% |
| **Net Profit Margin** | -12.6% | -2.8% | -26.2% | -150.8% | -36.1% | -36.8% |
| Return on Equity (ROE) | -- | -3.3% | -33.8% | -163.5% | -17.1% | -- |
| Return on Assets (ROA) | -9.1% | -2.1% | -20.3% | -102.8% | -14.3% | -- |
| Current Ratio | 2.42x | 1.64x | 1.92x | 2.21x | 2.31x | -- |
| Quick Ratio | 1.39x | 1.02x | 1.20x | 2.17x | 2.27x | -- |
| Debt to Equity | -- | 0.20x | 0.24x | 0.24x | 0.06x | -- |
| **Revenue Growth (YoY)** | -9.2% | -5.3% | +3.8% | +3.2% | +29.3% | -- |
| Gross Profit Growth (YoY) | -15.4% | -5.7% | +6.2% | +5.1% | +21.0% | -- |
| Operating Cash Flow Growth (YoY) | -- | -89358.1% | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | +9.2% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | 71.5% | 71.7% | 73.6% | 75.1% | 76.8% | 77.0% |
| **Operating Margin** | -1.7% | -2.4% | -5.6% | -9.8% | -9.5% | -12.7% | -14.6% | -17.6% |
| **Net Profit Margin** | -6.9% | -7.1% | -10.2% | -12.6% | 1.5% | -0.8% | -3.9% | -2.8% |
| Return on Equity (ROE) | -- | -- | -- | -- | -- | -- | -- | -3.3% |
| Return on Assets (ROA) | -5.1% | -5.3% | -7.5% | -9.1% | 1.1% | -0.6% | -3.0% | -2.1% |
| Current Ratio | 2.38x | 2.48x | 2.36x | 2.42x | 2.42x | 2.50x | 2.27x | 1.64x |
| Quick Ratio | 1.22x | 1.34x | 1.18x | 1.39x | 1.36x | 1.37x | 1.24x | 1.02x |
| Debt to Equity | -- | -- | -- | -- | -- | -- | -- | 0.20x |
| **Revenue Growth (YoY)** | +2.1% | +8.1% | +0.2% | -4.8% | -16.0% | -11.4% | -4.0% | -10.8% |
| Gross Profit Growth (YoY) | -- | -- | -1.3% | -13.4% | -21.7% | -20.1% | -5.2% | -8.6% |
| **Net Income Growth (YoY)** | -- | -- | -- | -137.0% | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -45.7% | +44.1% | -- | +233.6% | -- | -- | -- | -94.1% |
| Free Cash Flow Growth (YoY) | -51.4% | +47.3% | -- | -- | -- | -- | -- | -102.7% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
